Regional Monitoring EECA
by ECUO PLWH
Showing 1-47 of 47 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml6.75216.75213.5VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
2Republic of PolandGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)20mg/ml oral solution 240ml69.3950169.39503469.5Krajowe Centrum ds. AIDS2016YesYesNot specified
3Republic of LatviaGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml66.29-166.29--2015Not specifiedNot specifiedNot specified
4Republic of PolandGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)20mg/ml oral solution 240ml69.3950169.39503469.5Krajowe Centrum ds. AIDS2016YesYesNot specified
5Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.544172.54431902015Not specifiedNot specifiedNot specified
6Republic of MoldovaGovernmentViiv Healthcare UK LimitedZiagenAbacavir (ABC)20mg/ml oral solution 240ml59.98114159.981146837.72Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
7Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.5100172.510072502015Not specifiedNot specifiedNot specified
8Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.540172.54029002015Not specifiedNot specifiedNot specified
9Republic of BelarusGlobal FundGlaxoSmithKlineAbacavir (ABC)20mg/ml oral solution 240ml14.99165114.991652473.35UNDP/UNICEF2016YesNoNot specified
10UkraineGovernmentViiV HealthcareAbacavir (ABC)20mg/ml oral solution 240ml0.08119101510.08119101595281.22015Not specifiedNot specifiedNot specified
11GeorgiaGlobal FundHetero labs Ltd.Abacavir (ABC)20mg/ml oral solution 240ml7.521617.52161620partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
12Republic of KazakhstanGovernmentKievmedpreparat, UkraineAbacavir (ABC)20mg/ml oral solution 240ml119.485961119.4859671210.082015Not specifiedNot specifiedNot specified
13Republic of TajikistanGlobal FundViiV HealthcareAbacavir (ABC)20mg/ml oral solution 240ml8-18--2015Not specifiedNot specifiedNot specified
14Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml12-112--2015Not specifiedNot specifiedNot specified
15Republic of LatviaGovernmentViiv Healthcare UK LimitedZiagenAbacavir (ABC)20mg/ml oral solution 240ml82.6282182.62826774.84National Health Service (NHC)2016Not specifiedNot specifiedNot specified
16Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml37.44533137.4453319955.522015YesYesNot specified
17Russian FederationGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml45.621875145.6218759975002015Not specifiedNot specifiedNot specified
18Republic of PolandGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)20mg/ml oral solution 240ml69.39100169.391006939Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
19GeorgiaGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml6.834516.8345307.35partnership for supply. chain management (PFSCM)2016YesYesNot specified
20Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)600mg tab2.509760223203075.29200744151140162015Not specifiedNot specifiedNot specified
21UkraineGovernmentGlaxoSmithKlineAbacavir (ABC)300mg tab0.26828132406016.0913554218083.862015Not specifiedNot specifiedNot specified
22Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)300mg tab1.1333264384060684406429963522015Not specifiedNot specifiedNot specified
23Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.81253000060228.755001143752015Not specifiedNot specifiedNot specified
24UkraineGlobal FundGlaxoSmithKlineAbacavir (ABC)300mg tab0.425606025.5125.52015Not specifiedNot specifiedNot specified
25GeorgiaGlobal FundMYLAN LABORATORIES LTDAbacavir (ABC)300mg tab0.1832129606010.992162373.84partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
26Russian FederationGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab1.09328209206065.5913682897402.382015Not specifiedNot specifiedNot specified
27Republic of KazakhstanGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab0.0442343600602.6439060103118.42015Not specifiedNot specifiedNot specified
28Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.23336060141142015Not specifiedNot specifiedNot specified
29Kyrgyz RepublicGlobal FundHetero labs Ltd.Abacavir (ABC)300mg tab0.165338700609.926456398.4UNDP/UNICEF2016NoNoNot specified
30Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.1848606011.09111.092015Not specifiedNot specifiedNot specified
31Republic of LatviaGovernmentViiv Healthcare UK LimitedZiagenAbacavir (ABC)300mg tab3.98673840060239.2640153088National Health Service (NHC)2016Not specifiedNot specifiedNot specified
32Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDAbacavir (ABC)300mg tab0.1665420609.99769.93partnership for supply. chain management (PFSCM)2016NoYesNot specified
33Republiс of AzerbaijanGovernmentGlaxoSmithKlineAbacavir (ABC)300mg tab0.6048285606036.2947617274.042015YesYesNot specified
34Republic of ArmeniaGlobal FundCipla LtdAbacavir (ABC)300mg tab0.19569006011.71151345.5VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
35Russian FederationGovernmentDrugs technologyAbacavir-ABCAbacavir (ABC)300mg tab1.15965521206069.5410920275939072015Not specifiedNot specifiedNot specified
36Republic of PolandGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)300mg tab3.36271800060201.7630060528Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
37Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)150mg tab0.6933180606041.630112521.62015Not specifiedNot specifiedNot specified
38Republic of PolandGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)150mg tab3.46673000060208500104000Krajowe Centrum ds. AIDS2016YesYesNot specified
39Republic of LatviaGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.47026060208.211208.212015Not specifiedNot specifiedNot specified
40Republic of BelarusGlobal FundHetero labs Ltd.Abacavir (ABC)300mg tab0.18482991006011.09498555283.65UNICEF Supply Division20152015-05-24Not specifiedNot specifiedNot specified
41Republic of BelarusGovernmentHetero Labs + ФарматехAbacavir (ABC)300mg tab0.33429008406020.0515014301030.69Фарматех ЗАО2015Not specifiedNot specifiedNot specified
42Republic of BelarusGovernmentHetero Labs + ФарматехAbacavirAbacavir (ABC)300mg tab0.3667900840602215014330308Republican unitary enterprise "BELPHARMATSIYA"2016-02-18YesYesNo
43Republic of KazakhstanGovernmentMYLAN LABORATORIES LTDAbacavir (ABC)300mg tab0.04311091600602.58184860476938.812015Not specifiedNot specifiedNot specified
44Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.8125300060228.755011437.52015Not specifiedNot specifiedNot specified
45Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.181717406010.929316.1partnership for supply. chain management (PFSCM)2016NoYesNot specified
46Kyrgyz RepublicGlobal FundHetero labs Ltd.Abacavir (ABC)300mg tab0.2125211806012.753534500.75UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
47Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.81253900060228.75650148687.52015Not specifiedNot specifiedNot specified